Family Care Center Innovates Mental Health Treatments
Family Care Center has released exciting research that sheds light on a novel way to treat patients suffering from both anxiety and major depressive disorder (MDD). This groundbreaking study focuses on a recently developed treatment protocol known as sequential bilateral (SBL) repetitive transcranial magnetic stimulation (rTMS). The findings indicate that this innovative approach can significantly reduce anxiety symptoms in patients, effectively enhancing their overall mental health.
Understanding the SBL rTMS Protocol
The study assessed 82 individuals diagnosed with MDD, all of whom were experiencing moderate to severe anxiety. These patients underwent a total of 30 sessions utilizing the SBL rTMS protocol, and by the halfway point and conclusion of their treatment, remarkable reductions in anxiety symptoms were observed. The outcomes were measured using the Generalized Anxiety Disorder-7 (GAD-7) scale, which provided compelling evidence of the method’s effectiveness.
The Research Findings
In this research, the SBL rTMS protocol, designed by Family Care Center's Chief Medical Officer, Dr. Chuck Weber, introduces a unique technique. It begins with delivering high-frequency stimulation to the left side of the brain, followed by a theta burst pattern applied to the right side. This technique demonstrates promising potential for those grappling with dual challenges of depression and anxiety, paving the way for further studies in mental health advancements.
Implications for Future Treatments
Dr. Sabrina Segal, a co-author of the study, remarked, "This research underscores our dedication to exploring new ways to treat complex mental health conditions and advancing behavioral health." The dual focus of addressing depression and anxiety through advanced therapeutic protocols like the SBL rTMS demonstrates the progress being made in mental health treatment options. However, further investigation is essential to solidify these findings.
Track Record of Effectiveness
Since 2016, Family Care Center has established itself as a leader in transcranial magnetic stimulation, with over 75,000 successful treatments to date. Their integrated approach combines therapy, medication management, and TMS to achieve an impressive 95% positive outcome rate, notably higher than the national average of 52%. This strong track record showcases the effectiveness of their treatment strategies and their commitment to improving patient care.
More About Family Care Center
Family Care Center is a prominent name in national mental health services, striving to make a significant impact on community well-being. The organization prides itself on its top-rated multi-specialty clinicians who deliver comprehensive, evidence-based care tailored to the needs of patients of all ages. Besides their leading-edge therapy and psychiatric services, Family Care Center remains at the forefront of transcranial magnetic stimulation, a proven method for tackling a range of mental health issues, particularly depression. They are among the fastest-growing mental health care providers in the U.S., with over 35 locations across various states, continuously expanding their reach with the support of Revelstoke Capital Partners.
Frequently Asked Questions
What is the SBL rTMS protocol?
The SBL rTMS protocol involves delivering high-frequency stimulation to the left side of the brain, followed by a theta burst pattern to the right side, aimed at alleviating anxiety and depression symptoms.
How effective is this new treatment?
Research indicates significant reductions in anxiety symptoms among patients with major depressive disorder, suggesting a promising new avenue for treatment.
Who developed the SBL protocol?
Dr. Chuck Weber, the Chief Medical Officer of Family Care Center, developed this innovative protocol.
How many patients were involved in the study?
The study involved 82 patients diagnosed with major depressive disorder and moderate to severe anxiety.
What percentage of patients experience positive outcomes?
Family Care Center reports a 95% positive outcome rate across their treatments, significantly higher than the national benchmark.
